NCT00569374View on ClinicalTrials.gov

Safety and Tolerability of Modafinil for Methamphetamine Dependence

PHASE2CompletedINTERVENTIONAL
Enrollment

8

Participants

Timeline

Start Date

September 30, 2007

Primary Completion Date

September 30, 2008

Conditions
Methamphetamine Dependence
Interventions
DRUG

Modafinil

subjects attend clinic for the first week in order to receive meds; oral, 200mg/day doses for three days for initiation doses; increased to oral 400mg/day for the remainder of the trial (weeks 2-6); washout period during week 7

Trial Locations (1)

72205

University of Arkansas for Medical Sciences, Little Rock

All Listed Sponsors
collaborator

National Institute on Drug Abuse (NIDA)

NIH

lead

University of Arkansas

OTHER

NCT00569374 - Safety and Tolerability of Modafinil for Methamphetamine Dependence | Biotech Hunter | Biotech Hunter